Abstract:The emergence of drug resistance against the frontline antimalarials is a major challenge in the treatment of malaria. In view of emerging reports on drug-resistant strains of Plasmodium against artemisinin combination therapy, a dire need is felt for the discovery of novel compounds acting against novel targets in the parasite. In this study, we identified a novel series of quinolinepiperazinyl-aryltetrazoles (QPTs) targeting the blood stage of Plasmodium. In vitro anti-plasmodial activity screening revealed that most of the compounds showed IC50 < 10 μM against chloroquine-resistant PfINDO strain, with the most promising lead compounds 66 and 75 showing IC50 values of 2.25 and 1.79 μM, respectively. Further, compounds 64-66, 68, 75-77 and 84 were found to be selective (selectivity index >50) in their action against Pf over a mammalian cell line, with compounds 66 and 75 offering the highest selectivity indexes of 178 and 223, respectively. Explorations into the action of lead compounds 66 and 75 revealed their selective cidal activity towards trophozoites and schizonts. In a ring-stage survival assay, 75 showed cidal activity against the early rings of artemisinin-resistant PfCam3.1R539T. Further, 66 and 75 in combination with artemisinin and pyrimethamine showed additive to weak synergistic interactions. Of these two in vitro lead molecules, only 66 restricted rise in the percentage of parasitemia to about 10% in P. berghei-infected mice with a median survival time of 28 days as compared to the untreated control, which showed the percentage of parasitemia >30%, and a median survival of 20 days. Promising antimalarial activity, high selectivity, and additive interaction with artemisinin and pyrimethamine indicate the potential of these compounds to be further optimized chemically as future drug candidates against malaria.

Pyrido[1,2-a]pyrimidin-4-ones As Antiplasmodial Falcipain-2 Inhibitors

2-(3,4-Dihydro-4-oxothieno[2,3-d]pyrimidin-2-ylthio) Acetamides As a New Class of Falcipain-2 Inhibitors. 3. Design, Synthesis and Biological Evaluation

2-Amido-3-(1h-indol-3-yl)-n-substitued-propanamides As a New Class of Falcipain-2 Inhibitors. 1. Design, Synthesis, Biological Evaluation and Binding Model Studies

In silico investigation of falcipain-2 inhibition by hybrid benzimidazole-thiosemicarbazone antiplasmodial agents: A molecular docking, molecular dynamics simulation, and kinetics study

Novel Dual Inhibitors Against FP-2 and PfDHFR As Potential Antimalarial Agents: Design, Synthesis and Biological Evaluation

Design and Synthesis of Small Molecular Dual Inhibitor of Falcipain-2 and Dihydrofolate Reductase As Antimalarial Agent

Synthesis And Antimalarial Activity Of Novel Dihydro-Artemisinin Derivatives

Synthesis, Design, and Structure–Activity Relationship of the Pyrimidone Derivatives As Novel Selective Inhibitors of Plasmodium Falciparum Dihydroorotate Dehydrogenase

Peptidomimetic Nitriles As Selective Inhibitors for the Malarial Cysteine Protease Falcipain-2

Discovery of New Antimalarial Agents: Second-generation Dual Inhibitors Against FP-2 and PfDHFR Via Fragments Assembely

Synthesis, design, and optimization of a potent and selective series of pyridylpiperazines as promising antimalarial agents

Identification of diverse natural products as falcipain-2 inhibitors through structure-based virtual screening.

Structure-Function of Falcipains: Malarial Cysteine Proteases

Synthesis and evaluation of fluorinated piperazine‐hydroxyethylamine analogues as potential antiplasmodial candidates

Novel quinolinepiperazinyl-aryltetrazoles targeting the blood stage of Plasmodium falciparum

Dietary Flavonoids Fisetin and Myricetin: Dual Inhibitors of Plasmodium Falciparum Falcipain-2 and Plasmepsin II.

4-Substituted Thieno[3,2- d]pyrimidines as Dual-Stage Antiplasmodial Derivatives

2,8-Disubstituted-1,5-naphthyridines as Dual Inhibitors of Plasmodium falciparum Phosphatidylinositol-4-kinase and Hemozoin Formation with In Vivo Efficacy

Purine containing carbonucleoside phosphonate analogues as novel chemotype for Plasmodium falciparum Inhibition

Inhibition of falcilysin from Plasmodium falciparum by interference with its closed-to-open dynamic transition

Discovery of a Natural Fluorescent Probe Targeting the Plasmodium Falciparum Cysteine Protease Falcipain-2